Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, July the 26th 2016, 07:00-10:00

ZORA's new graphical user interface will be relaunched (For further infos watch out slideshow ZORA: Neues Look & Feel). There will be short interrupts on ZORA Service between 07:00am and 10:00 am. Please be patient.

Suormala, Terttu; Baumgartner, Matthias; Fowler, Brian (2008). Biotinidase. In: Blau, Nenad; Duran, Marinus; Gibson, K Michael. Laboratory Guide to the Methods in Biochemical Genetics. Berlin: Springer Verlag, 253-264.

Full text not available from this repository.

View at publisher


Biotinidase (EC is required for the recycling of biotin and for the utilization of protein bound biotin from the diet. Biotinidase deficiency (MIM 253260) is inherited as an autosomal recessively trait. Patients become progressively biotin deficient which results in reduced activity of the 4 biotin-dependent carboxylases existing in man, and severe life-threatening illness. Oral biotin substitution effectively protects against disease or reverses symptoms. Delayed treatment may result in irreversible neurological damage. Time of onset and severity of illness depend on the level of residual enzyme activity necessitating early (preferably neonatal) assessment of biotinidase activity. Patients are classified as having profound (0-10% residual activity) or partial (residual activity >10-30%) deficiency, or a Km defect due to reduced affinity of biotinidase for its substrate biocytin. Heterozygous individuals show activities intermediate between the deficient and normal activity. The natural substrate of biotinidase is biocytin but it can also act on artificial biotinyl-derivatives. Biotinidase activity in plasma is usually assayed using biotinyl-p-aminobenzoic acid (biotinyl-PABA) as substrate. Liberated PABA is converted to a purple azo dye and quantitated spectrophotometrically. This simple, reproducible and easy to perform colorimetric assay for the diagnosis of patients with different forms of biotinidase deficiency, including those with a Km defect, is described.



Additional indexing

Item Type:Book Section, not refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Deposited On:27 Feb 2009 11:16
Last Modified:05 Apr 2016 13:00
Publisher:Springer Verlag
ISBN:978-3-540-76697-1 (Print) 978-3-540-76698-8 (Online)
Publisher DOI:10.1007/978-3-540-76698-8_15

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page